BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14726167)

  • 21. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.
    Chang AM; Smith MJ; Bloem CJ; Galecki AT; Halter JB
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E906-11. PubMed ID: 15213063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.
    Eckert C; Biondi A; Seeger K; Cazzaniga G; Hartmann R; Beyermann B; Pogodda M; Proba J; Henze G
    Lancet; 2001 Oct; 358(9289):1239-41. PubMed ID: 11675066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of glycaemic status in young people with clinical insulin resistance; fasting glucose, fasting insulin or an oral glucose tolerance test?
    Garnett SP; Srinivasan S; Birt SG; Ambler GR; Lawrie EA; Cowell CT; Craig ME
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):475-80. PubMed ID: 19656159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.
    Valerio G; Licenziati MR; Iannuzzi A; Franzese A; Siani P; Riccardi G; Rubba P
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):279-84. PubMed ID: 16679220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional status of pancreatic islet in acute leukemia.
    Lin FR; Yao EG; Xu SR; Wei JP; Zhao ZS; Huang ZG; Chu SC; Liu DG
    Chin Med J (Engl); 1994 Nov; 107(11):827-31. PubMed ID: 7867389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of insulin sensitivity and secretion indices from oral glucose tolerance testing in subjects with fasting euglycemia but impaired 2-hour plasma glucose.
    Theodorakis MJ; Muller DC; Carlson O; Egan JM
    Metabolism; 2003 Nov; 52(11):1523-4; discussion 1524-5. PubMed ID: 14635635
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
    Cheok MH; Evans WE
    Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visuomotor function in children treated for acute lymphoblastic leukaemia with chemotherapy only.
    Knight S; McCarthy M; Anderson V; Hutchinson E; De Luca C
    Dev Neuropsychol; 2014; 39(2):101-12. PubMed ID: 24571929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.
    Chow EJ; Pihoker C; Friedman DL; Lee SJ; McCune JS; Wharton C; Roth CL; Baker KS
    Pediatr Blood Cancer; 2013 Apr; 60(4):621-6. PubMed ID: 23042765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute lymphoblastic leukaemia presenting as euglycaemic ketoacidosis in a patient with type 1 diabetes.
    Gavillet M; Schaefer N; Lapointe AK; Spertini O; Cairoli A
    Lancet Haematol; 2021 Jul; 8(7):e534. PubMed ID: 34171283
    [No Abstract]   [Full Text] [Related]  

  • 32. [Oral cavity changes in children with acute leukemia during long-term chemotherapy].
    Wacińska-Drabińska M; Moszczeńska-Cieślikowska B; Rokicka-Milewska R; Lipnicki D
    Czas Stomatol; 1989; 42(7-9):436-40. PubMed ID: 2488218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of leukaemia in paediatric haematology day hospital].
    Héritier S; Morand K; Courcoux MF; Leverger G
    Soins Pediatr Pueric; 2015; (285):17-21. PubMed ID: 26183094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes.
    Schmiegelow K
    Eur J Med Genet; 2016 Dec; 59(12):654-660. PubMed ID: 26876989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine blood counts in children with acute lymphoblastic leukaemia after completion of therapy: are they necessary?
    Gandhi M; Rao K; Chua S; Saha V; Lilleyman J; Shankar A
    Br J Haematol; 2003 Aug; 122(3):451-3. PubMed ID: 12877672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced leucine catabolism induced by chemotherapy in leukemic children.
    Kibirige MS; Morris Jones PH; Stevens RF; Rennie MJ
    Pediatr Hematol Oncol; 1989; 6(1):11-6. PubMed ID: 2641694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and management of corticosteroid-induced hyperglycaemia in paediatric acute lymphoblastic leukaemia.
    Gregoriou K; Craigie I; Gibson B; Mason A; Shaikh MG
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28085. PubMed ID: 31736211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trial of novel leukaemia drug is stopped for second time after two more deaths.
    Hawkes N
    BMJ; 2016 Nov; 355():i6376. PubMed ID: 27886983
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of acute lymphoblastic leukemia therapy on attention and working memory in children.
    Reddick WE; Conklin HM
    Expert Rev Hematol; 2010 Dec; 3(6):655-9. PubMed ID: 21091140
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-compliance with oral chemotherapy in childhood leukaemia.
    Lilleyman JS; Lennard L
    BMJ; 1996 Nov; 313(7067):1219-20. PubMed ID: 8939095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.